AstraZeneca targets $80 billion in total revenue by 2030 in ‘post-Covid era’

Pharmaceutical company AstraZeneca is planning to increase its total revenue by 75% and release 20 new medicines by 2030, including cancer treatments.

Tags: No tags

Add a Comment

Your email address will not be published. Required fields are marked *